Barry J. Marshall, MB BS W.Aust., FRACP, FRS, FAA
Nobel Laureate; Professor, Clinical Microbiology, University of Western Australia
Twitter: @barjammar
Session:
DDW Tracks:
- Clinical Practice
- Microbiome in Gastrointestinal and Liver Diseases
- Stomach and Small Bowel Disorders
Date and Time:
Saturday, May 22, 10–11:30 a.m.
CME:
1.5 hours
Session Description
H. pylori management has become increasingly challenging due to widespread antimicrobial resistance worldwide. This session will provide invaluable and practical information to help clinicians evaluate resistance in their population of interest, and to develop strategies to optimize treatment success. As an exciting introduction, Barry J. Marshall, MD, MB BS W.Aust., FRACP, FRS, FAA, will review how H. pylori was first cultured in 1982 and how the initial findings bumped up inconveniently against the existing medical dogma during his lecture, “The Discovery Of H. Pylori — Scientific Resistance and How We Overcame It.”
Moderated by Steven F. Moss, MD, and David A. Peura, MD, the following additional topics will be covered:
| Speaker | Presentation Title |
|---|---|
| David Y. Graham, MD Professor of Medicine, Baylor College of Medicine | The Global Picture of H. Pylori Antimicrobial Resistance |
| Francis Megraud, MD Professor of Bacteriology, University of Bordeaux; Head of the Laboratory of Bacteriology, Bordeaux Hospital, France | Practical Approach to Measuring and Monitoring Antibiotic Resistance in H. Pylori |
| Peter Malfertheiner, MD Professor, Department of Gastroenterology, Hepatology and Infectious Diseases, Otto v. Guericke University, Germany | Choosing an Optimal Regimen in 2021 |
This session is included in the cost of registration for DDW 2021 and will be available to watch live or on demand until Aug. 23, 2021. Discounted registration rates are available through March 31. View the DDW Online Planner for the full DDW agenda over May 21-23.
